Latest Consumer Staples News

Treasury Wine Estates reported a robust FY25 with a 17% rise in earnings driven by Penfolds and DAOU, alongside a strategic shift to a luxury-focused operating model and a $200 million share buyback plan.

Treasury Wine Estates has announced a fully franked ordinary dividend of AUD 0.20 per share for the six months ending June 2025, with a Dividend Reinvestment Plan available to shareholders.

Treasury Wine Estates posts robust FY25 results led by luxury brands Penfolds and DAOU, while unveiling a new operating model and CEO transition.

The Calmer Co. has secured a long-term lease for its Navua facility in Fiji, replacing a planned property purchase and freeing up capital to accelerate its US market expansion.

The Calmer Co. International Limited has reported an 81% surge in retail sales through Coles in July, driven by a significant expansion in store presence and strong consumer demand for its natural relaxation products.

Pure Foods Tasmania has raised $150,000 through a strategic share and option placement, signaling strong investor confidence in its ongoing turnaround strategy.

Pure Foods Tasmania reports solid progress in its turnaround strategy with significant cost reductions and improved product quality, setting the stage for profitable growth in FY26.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.

Althea Group Holdings reported significant cash outflows in Q2 2025 due to one-off costs but anticipates operational improvements and revenue growth from its North American business units.

Health and Plant Protein Group Ltd (HPP) ended FY25 Q4 with a strong cash position following a significant IRS payment, while signaling plans for shareholder returns and confidential corporate opportunities.

Aumake Limited reported a remarkable 213% surge in quarterly cash receipts, driven by exclusive distribution agreements and strategic cost reductions, setting the stage for profitability in FY26.

Elixinol Wellness reported a 10.8% revenue increase in Q2 2025, supported by improved cash receipts and a focused cost containment program. The company secured new funding and launched a menopause-targeted product, positioning itself for margin growth and profitability in H2.